Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

PMID:
22686416
[PubMed - indexed for MEDLINE]
Free Article
2.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

PMID:
22686415
[PubMed - indexed for MEDLINE]
Free Article
3.

[Characteristics of the kidney lesion in a patient with Sneddon's syndrome].

Kirsanova TV, Kozlovskaia NL, Kalashnikova LA, Smirnova TV, Roshchupkina SV, Khafizova EIu.

Ter Arkh. 2009;81(8):73-7. Russian.

PMID:
19799206
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk